The most durable specialty healthcare businesses of the next decade won't sit inside the pharma-insurance complex — they'll route around it. The advantage compounds for platforms that own the clinical protocol, the practitioner network, and the patient relationship simultaneously, in categories where conventional medicine has under-delivered for a generation.
Specialist-led platforms in neuro and functional health. Clinical authority compounds into a single moat.
Direct-to-patient brands feeding the clinical infrastructure. Acquisition is the patient relationship.
The intellectual property layer. Protocols and certification owned at the hub, not licensed.
The spokes that deliver care, train other practitioners, and grow the evidence base.
We back specialist-led platforms in neurodevelopmental and functional health where clinical authority, consumer acquisition, and operating infrastructure are designed to compound into a single moat. The hub holds the IP and the protocol; the spokes deliver care, train practitioners, and acquire the families who become the evidence base. Capital is patient and operationally engaged — these are systems built to last decades, not exits to engineer.